b'VISIONARY RESEARCHERSThe Pediatric Cancer Research Foundation supported these imaginative and far-sighted scientists whose findingsset the stage for future advances in care:Mitchell Cairo, MD, New York Medical College, Maria Fareri Childrens HospitalCancer genetics, tumor immunology, and targeted treatments for childhood and adolescenthematological malignancies and solid tumorsBrian Crompton, MD, Dana-Farber Cancer InstituteProspective validation of a prognostic liquid biopsy approach for pediatric Ewing SarcomaGregory Friedman, MD, University of Alabama at BirminghamDirected drug delivery for pediatric High-Grade Glioma Josephine HaDuong, MD, Childrens Hospital of Orange County and University of California IrvineComprehensive, coordinated clinical, imaging and histological database for the study ofneurological outcomes of cancer and cancer treatmentsRintaro Hashizume, MD, PhD, Ann & Robert H. Lurie Childrens Hospital of ChicagoIntranasal delivery of targeting nanoliposomal therapeutics for pediatric GliomaMichael Hogarty, MD, The Childrens Hospital of PhiladelphiaDeveloping user-friendly tests to determine the appropriate protein-based treatment response for childhood NeuroblastomasEugenie Kleinerman, MD, University of Texas M.D. Anderson Cancer CenterCombining a novel dendritic cell vaccine with checkpoint blockade for Osteosarcoma therapyMichelle Monje, MD, PhD, Lucile Packard Childrens Hospital Stanford UniversityTherapies for High-Grade GliomaTheodore Moore, MD, Mattel Childrens Hospital, UCLACellular and gene therapies, nanotechnology and stem cell biologyAshley Plant-Fox, MD, Ann & Robert H. Lurie Childrens Hospital of ChicagoCombination immunotherapy for Diffuse Intrinsic Pontine Glioma (DIPG)Sarah Richman, MD, PhD,Childrens Hospital Los AngelesCAR T cell therapy in pediatric brain tumorsKathleen Sakamoto, MD, PhD, Lucile Packard Childrens Hospital Stanford UniversityTargeting mitochondrial pathways in pediatric Acute Myeloid Leukemia (AML)Surojit Sarkar, PhD, Seattle Childrens Research Institute Designing self-driving CAR T cell immunotherapies for metastatic solid tumorsElliot Stieglitz, MD, University of California, San Francisco Benioff Childrens HospitalInnovative tests to determine treatment responsiveness for Juvenile Myelomonocytic Leukemia (JMML) Masataka Suzuki, PhD, Baylor College of MedicineImmunotherapy and CAR NK cell therapy for pediatric SarcomaRajkumar Venkatramani, MD, Texas Childrens HospitalMolecular characterization of undifferentiated SarcomasLeo Wang, MD, PhD, City of Hope National Medical CenterFine-tuning chimeric antigen receptor signaling to improve CAR T cell therapy for pediatric brain tumors9'